As Q1 corporate earnings season progresses, earnings delivery is following a distinct narrative: demand remains resilient across the economy, but performance is increasingly defined by margin conversion. Higher input costs are flowing directly into top-line revenue- a classic reflationary signature.
The Macro Picture: Ex-Energy Strength
Across 345 reported NSE 500 companies, headline sales, EBITDA, and PAT grew 23.0%, 5.9%, and 6.0% YoY, respectively. Energy continues to distort these numbers significantly. Stripping out Energy, 333 companies delivered far stronger fundamentals: Sales grew 18.2%, EBITDA expanded 14.0%, and PAT rose 16.5% YoY.
Earnings breadth remains broad-based, with 13 out of 24 sectors delivering PAT growth above 15%. This expansion is led by Banks, NBFCs, Metals & Mining, Utilities, Capital Goods, Telecom, and Capital Markets. Domestic economic indicators reinforce this health through resilient credit growth, strong Auto volumes, selective export recoveries, and improving discretionary spending.
Market Cap Breakdown:
Excluding Energy, performance across market capitalizations:
- Small Cap (154 companies): PAT expanding 26% YoY, backed by 20% Sales and 17% EBITDA growth.
- Mid Cap (101 companies): 18% Sales, 19% EBITDA, and 24% PAT growth YoY.
- Large Cap (74 companies): Delivered steady 18% Sales and 14% EBITDA growth, resulting in 16% YoY PAT growth.
- Nifty 50 (39 companies reported ex-energy): Sales grew 17% YoY, but lagged in EBITDA growth (9% YoY), bringing PAT growth to 14% YoY.
Must Read: The ₹8.60 Spread: Where the Grid’s Profit Pool Is Moving
Key Sectoral Read-Throughs
FMCG: Input Inflation vs. Volume Recovery
Underlying demand is reviving, but raw material costs are weighing on profitability. Across 21 reported companies, Sales/EBITDA/PAT grew 12%/2%/-2% YoY. Excluding ITC—where tax increases dragged cigarette volumes down 6–7% and standalone EBITDA down 28%—the sector printed healthy growth of 18%/17%/11%.
Auto & Auto Ancillaries: Volume Demand vs. Commodity Squeeze
Auto OEMs experienced solid top-line demand (+28% YoY), but commodity inflation capped EBITDA (+8%) and PAT (+8%). Maruti Suzuki reported 36% revenue growth, but PAT fell 11% due to commodity costs and temporary settlement timing impacts. M&M indicated Q1 marked its margin trough after absorbing 400–450 bps of commodity inflation. In Auto Ancillaries (+20% sales, +15% PAT), Samvardhana Motherson expanded EBITDA 26% on operational restructuring, while Motherson Sumi Wiring and UNO Minda saw margins pressured by copper prices and wage inflation.
Consumer Discretionary: Positive Operating Leverage
Discretionary consumption remains the standout performer, achieving 42% sales, 19% EBITDA, and 62% PAT YoY growth. Nykaa surged (+29% sales, +215% PAT) on improved customer economics, while Leela Palaces reported 28% revenue growth with RevPAR rising 17%. Swiggy delivered 37% revenue growth, though Instamart expansion pushes profitability further out.
Pharmaceuticals: Cost Synergies and Margin Shifts
Pharma posted 14% revenue and 8% PAT growth. Divi’s Laboratories delivered a good quarter with revenue up 28% and PAT up 66% YoY (EBITDA margin hitting 40.7%). Torrent Pharma revenue surged 55% following JB Chemicals consolidation with cost synergies ahead of plan.
Inference:
In a reflationary market, top-line growth is widespread, but earnings delivery requires strict execution. We remain selectively positioned in businesses that possess strong pricing power, category leaders with superior operational agility, and high-conviction financial institutions best placed to capture resilient domestic credit growth.
